ID27554A - Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif - Google Patents

Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif

Info

Publication number
ID27554A
ID27554A IDW20002641A ID20002641A ID27554A ID 27554 A ID27554 A ID 27554A ID W20002641 A IDW20002641 A ID W20002641A ID 20002641 A ID20002641 A ID 20002641A ID 27554 A ID27554 A ID 27554A
Authority
ID
Indonesia
Prior art keywords
aerosols
active materials
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
IDW20002641A
Other languages
English (en)
Inventor
Daniel P Mcnamara
George A De Stefano
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26046888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27554(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1998127178 external-priority patent/DE19827178A1/de
Priority claimed from DE1998142963 external-priority patent/DE19842963A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ID27554A publication Critical patent/ID27554A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20002641A 1998-06-18 1999-06-08 Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif ID27554A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1998127178 DE19827178A1 (de) 1998-06-18 1998-06-18 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
DE1998142963 DE19842963A1 (de) 1998-09-19 1998-09-19 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen

Publications (1)

Publication Number Publication Date
ID27554A true ID27554A (id) 2001-04-12

Family

ID=26046888

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002641A ID27554A (id) 1998-06-18 1999-06-08 Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif

Country Status (33)

Country Link
EP (1) EP1087750B1 (id)
JP (1) JP2003522102A (id)
KR (1) KR100600423B1 (id)
CN (1) CN1161104C (id)
AR (1) AR019690A1 (id)
AT (1) ATE253896T1 (id)
AU (1) AU759222B2 (id)
BG (1) BG65252B1 (id)
BR (1) BR9911351A (id)
CA (1) CA2335065C (id)
CO (1) CO5070580A1 (id)
CZ (1) CZ300910B6 (id)
DE (1) DE69912781T2 (id)
DK (1) DK1087750T3 (id)
EE (1) EE04450B1 (id)
ES (1) ES2211108T3 (id)
HK (1) HK1037974A1 (id)
HR (1) HRP20000867B1 (id)
HU (1) HU229064B1 (id)
ID (1) ID27554A (id)
IL (2) IL140353A0 (id)
ME (1) ME00838B (id)
MY (1) MY121073A (id)
NO (1) NO329416B1 (id)
NZ (1) NZ509418A (id)
PL (1) PL193695B1 (id)
PT (1) PT1087750E (id)
RS (1) RS49977B (id)
RU (1) RU2218152C2 (id)
SK (1) SK284756B6 (id)
TR (1) TR200003721T2 (id)
TW (1) TW528606B (id)
WO (1) WO1999065464A1 (id)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6479035B1 (en) 1999-09-11 2002-11-12 Smithkline Beecham Corporation Pharmaceutical formulation of fluticasone propionate
DE60017450T2 (de) * 1999-11-23 2006-03-02 Glaxo Group Ltd., Greenford Pharmazeutische formulierungen enthaltend salmeterol
ATE291898T1 (de) * 1999-12-24 2005-04-15 Glaxo Group Ltd Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
AU2000250701B2 (en) * 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
HU226527B1 (hu) 2001-09-18 2009-03-30 Nycomed Danmark Aps Készítmények nátha kezelésére
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8061350B2 (en) 2006-06-02 2011-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process and device for dosing pharmaceutical agents
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
JP2012520701A (ja) 2009-03-17 2012-09-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 小出し器具、貯蔵器具及び調合薬を小出しする方法
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
CA2781792C (en) 2009-11-25 2019-04-02 Boehringer Ingelheim International Gmbh Nebulizer
EP3020393B1 (en) 2009-12-16 2020-10-07 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
US10195374B2 (en) 2014-05-07 2019-02-05 Boehringer Ingelheim International Gmbh Container, nebulizer and use
ES2913297T3 (es) 2014-05-07 2022-06-01 Boehringer Ingelheim Int Nebulizador
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
WO2020152548A1 (en) * 2019-01-24 2020-07-30 Glenmark Pharmaceuticals Limited Stable aerosol inhalation compositions of formoterol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
CZ284203B6 (cs) * 1992-12-09 1998-09-16 Boehringer Ingelheim Pharmaceuticals Inc. Tekutý aerosolový přípravek obsahující léčivo a způsob stabilisace tohoto prostředku
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation

Also Published As

Publication number Publication date
AR019690A1 (es) 2002-03-13
KR100600423B1 (ko) 2006-07-13
EP1087750A1 (en) 2001-04-04
DK1087750T3 (da) 2004-01-26
EE200000759A (et) 2002-04-15
KR20010072621A (ko) 2001-07-31
WO1999065464A1 (en) 1999-12-23
EP1087750B1 (en) 2003-11-12
PT1087750E (pt) 2004-02-27
BG105033A (en) 2001-09-28
YU80000A (sh) 2003-04-30
PL345685A1 (en) 2002-01-02
NZ509418A (en) 2003-06-30
MY121073A (en) 2005-12-30
AU759222B2 (en) 2003-04-10
BR9911351A (pt) 2001-03-13
IL140353A (en) 2006-09-05
CZ20004750A3 (en) 2001-05-16
CA2335065A1 (en) 1999-12-23
HRP20000867A2 (en) 2001-10-31
HUP0104734A3 (en) 2003-05-28
HRP20000867B1 (en) 2010-10-31
HUP0104734A2 (hu) 2002-05-29
JP2003522102A (ja) 2003-07-22
CO5070580A1 (es) 2001-08-28
NO20006318L (no) 2001-01-30
DE69912781T2 (de) 2004-10-21
TW528606B (en) 2003-04-21
CZ300910B6 (cs) 2009-09-09
AU4552199A (en) 2000-01-05
EE04450B1 (et) 2005-04-15
RS49977B (sr) 2008-09-29
ATE253896T1 (de) 2003-11-15
TR200003721T2 (tr) 2001-06-21
PL193695B1 (pl) 2007-03-30
ME00838B (me) 2008-09-29
IL140353A0 (en) 2002-02-10
ES2211108T3 (es) 2004-07-01
HK1037974A1 (en) 2002-03-01
BG65252B1 (bg) 2007-10-31
CA2335065C (en) 2008-06-03
SK284756B6 (sk) 2005-11-03
SK19392000A3 (sk) 2001-07-10
RU2218152C2 (ru) 2003-12-10
CN1307470A (zh) 2001-08-08
DE69912781D1 (de) 2003-12-18
HU229064B1 (en) 2013-07-29
NO329416B1 (no) 2010-10-18
NO20006318D0 (no) 2000-12-12
CN1161104C (zh) 2004-08-11

Similar Documents

Publication Publication Date Title
ID27554A (id) Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif
DK1073417T3 (da) Farmaceutisk aerosolformulering
ATE222751T1 (de) Pharmazeutische aerosolzusammensetzung
DE69530325D1 (de) Aerosol-arzneiformulierungen
NO992339D0 (no) Farmas°ytiske formuleringer
EE200100714A (et) Farmatseutiliste ravimvormide pihustamissüsteemidja -meetodid
PT1001813E (pt) Formulacoes farmaceuticas contendo voriconazole
ATE234078T1 (de) Pharmazeutische omeprazol-formulierung
NO991407D0 (no) Legemiddelaerosolformuleringer som omfatter budesonid
DE69830154D1 (de) Pharmazeutische zusammensetzungen
ID30032A (id) Formulasi farmasi
SI1087750T1 (en) Pharmaceutical formulations for aerosols with two or more active substances
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger